Zenara Pharma Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No. 83/B, 84, 87 to 96, Phase III, IDA Cherlapally, Hyderabad, Telangana 500051, India (IND)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3005485158 · DUNS 924839850
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-05-21
Drugs this plant is listed as making
9 distinct drugs across 20 products name this site in their FDA label.
- DichlorphenamideCycle Pharmaceuticals Ltd.
- Eltrombopag OlamineHikma Pharmaceuticals USA Inc.
- frovatriptan succinateIngenus Pharmaceuticals, LLC
- MethazolamidePrecision Dose, Inc.
- MetolazoneIngenus Pharmaceuticals LLC
- Mexiletine HydrochlorideRising Pharma Holdings, Inc.
- PrucaloprideCipla USA Inc.
- Sertraline HydrochlorideCipla USA Inc.
- VigabatrinUpsher-Smith Laboratories, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.